IHG-1 Promotes Mitochondrial Biogenesis by Stabilizing PGC-1α
Authors:
- Fionnuala B. HickeyFHFionnuala B. Hickey
- James B. CorcoranJCJames B. Corcoran
- Neil G. DochertyNeil G. Docherty
- Brenda GriffinBGBrenda Griffin
- Una BhreathnachUBUna Bhreathnach
- Fiona FurlongFiona Furlong
- Finian MartinFMFinian Martin
- Catherine GodsonCGCatherine Godson
- Madeline MurphyMMMadeline Murphy
Open Access
- 1 August 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 22 (8) , 1475-1485
Abstract
Increased expression of Induced-by-High-Glucose 1 (IHG-1) associates with tubulointerstitial fibrosis in diabetic nephropathy. IHG-1 amplifies TGF-β1 signaling, but the functions of this highly-conserved protein are not well understood. IHG-1 contains a putative mitochondrial-localization domain, and here we report that IHG-1 is specifically localized to mitochondria. IHG-1 overexpression increased mitochondrial mass and stabilized peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α). Conversely, inhibition of IHG-1 expression decreased mitochondrial mass, downregulated mitochondrial proteins, and PGC-1α-regulated transcription factors, including nuclear respiratory factor 1 and mitochondrial transcription factor A (TFAM), and reduced activity of the TFAM promoter. In the unilateral ureteral obstruction model, we observed higher PGC-1α protein expression and IHG-1 levels with fibrosis. In a gene-expression database, we noted that renal biopsies of human diabetic nephropathy demonstrated higher expression of genes encoding key mitochondrial proteins, including cytochrome c and manganese superoxide dismutase, compared with control biopsies. In summary, these data suggest that IHG-1 increases mitochondrial biogenesis by promoting PGC-1α-dependent processes, potentially contributing to the pathogenesis of renal fibrosis.Keywords
This publication has 61 references indexed in Scilit:
- Prevention of diabetic nephropathy in Ins2+/−AkitaJ mice by the mitochondria-targeted therapy MitoQBiochemical Journal, 2010
- Peroxisome Proliferator-activated Receptor γ Co-activator 1α (PGC-1α) and Sirtuin 1 (SIRT1) Reside in MitochondriaJournal of Biological Chemistry, 2010
- Renal fibrosis is attenuated by targeted disruption of K Ca 3.1 potassium channelsProceedings of the National Academy of Sciences, 2009
- PGC-1α is coupled to HIF-1α-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cellsProceedings of the National Academy of Sciences, 2009
- A PGC-1α-O-GlcNAc Transferase Complex Regulates FoxO Transcription Factor Activity in Response to GlucoseJournal of Biological Chemistry, 2009
- Oxidants and Ca+2 induce PGC-1α degradation through calpainArchives of Biochemistry and Biophysics, 2008
- IHG-1 Amplifies TGF-β1 Signaling and Is Increased in Renal FibrosisJournal of the American Society of Nephrology, 2008
- SCFCdc4 acts antagonistically to the PGC-1α transcriptional coactivator by targeting it for ubiquitin-mediated proteolysisGenes & Development, 2008
- Dynamic regulation of PGC‐1α localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress responseAging Cell, 2007
- Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibresNature, 2002